Information Provided By:
Fly News Breaks for October 26, 2016
NVS
Oct 26, 2016 | 08:18 EDT
Leerink analyst Seamus Fernandez lowered his price target for Novartis to $80 from $89 after a "disappointing" Q3 performance despite bottom-line beat. The analyst reiterates a Market Perform rating on the shares.